Search filters

List of works by Zoltan Kalo

A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder.

scientific article

A microcost analysis of radiation therapy of localized prostate cancer

scientific article published in March 2016

A systematic review of the indirect costs of schizophrenia in Europe

scientific article published on 01 December 2018

A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study

scientific article published on 28 January 2018

Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology

scientific article published on 20 May 2019

An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets

scientific article published on 30 March 2018

An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation

scientific article published in January 2004

Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets

scientific article published on 11 May 2017

Assessment of the pharmaceutical expenditure in Hungary

scientific article published in January 2010

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology

scientific article

Barriers and facilitators of exploiting the potential of value-added medicines

scientific article published on 23 April 2020

Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries

scientific article published on 07 December 2018

Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence

scientific article published on 19 November 2019

Benefits of investment into modern medicines in Central-Eastern European countries.

scientific article published on 19 December 2013

CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES.

scientific article published on February 2016

Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary

scientific article published on 25 July 2013

Challenges Along The Road to Universal Health Coverage In Egypt, An Hio Perspective

scientific article

Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group

article

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

article

Comparative Cost-Effectiveness Study of Modern Radiation Therapies in Hungary for Localized Prostate Cancer

scientific article published on 26 October 2014

Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries

scientific article published on 15 February 2019

Contribution of clinical trials to gross domestic product in Hungary.

scientific article

Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary

scientific article published on 26 October 2014

Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model

scientific article

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer.

scientific article published on 22 December 2017

Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer

scientific article published on 19 January 2016

Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes.

scientific article published on 17 February 2016

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary.

scientific article

Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives

scientific article published on 01 April 2004

Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature review

scientific article published on 01 January 2019

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia

scientific article published on 29 December 2018

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries

scientific article published on 01 July 2020

Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments

scientific article

Differential pricing of new pharmaceuticals in lower income European countries

scientific article published on December 2013

Direct healthcare cost of schizophrenia - European overview

scientific article published on 3 February 2018

Does therapeutic reference pricing always result in cost-containment? The Hungarian evidence

scientific article published on 30 May 2006

EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control

scientific article

Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania

scientific article

Economic aspects of renal transplantation

scientific article

Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation

scientific article published in February 2005

Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary

scientific article published on 01 September 2001

European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries

scientific article published on 05 June 2020

External Reference Pricing for Pharmaceuticals-A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

scientific article published on 12 August 2019

Fair global drug pricing

scientific article published on 28 September 2018

Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa

scientific article published in September 2013

Guidance toward the implementation of multicriteria decision analysis framework in developing countries

scientific article published on 24 August 2018

HTA Implementation Roadmap in Central and Eastern European Countries.

scientific article published on 14 January 2016

HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status.

scientific article

Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives

scientific article published on 04 October 2019

Health technology assessment: a European collaboration ⬇️

scientific article published on February 1, 2011

How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia.

scientific article published on 13 June 2019

How To Assess The Value Of The Drug? An Overview On Producing Economic Evidence In The R&D Process

scientific article published on 01 October 2016

How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries? - the good, the bad, and the ugly ways

scientific article published on 10 December 2019

Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status

scientific article published on 21 February 2020

Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions Workshop

scientific article published on 01 October 2016

Implementation of palliative care consult Service in Hungary - integration barriers and facilitators

scientific article published on 27 March 2020

Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries

scientific article

Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries

scientific article

Implications of external price referencing of pharmaceuticals in Middle East countries.

scientific article published on 18 June 2015

Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary

scientific article published on 18 September 2019

Investment Aspects of Generic Drug Policies in Countries With Severe Resource Constraints

scientific article published on 26 October 2014

Is there a fair allocation of healthcare research funds by the European Union?

article

Is there a reason for concern or is it just hype? - A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars.

scientific article

Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes

scientific article published on 11 July 2014

Medical and economic burden of influenza in the elderly population in central and eastern European countries

scientific article

Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation

scientific article published in January 2003

Methodology of International Comparison of Pharmaceutical Prices

scientific article published on 20 October 2015

Modeling cost-effectiveness of cervical cancer screening in Hungary.

scientific article published in January 2012

Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

scientific article published on 8 January 2016

Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

scientific article published on 07 March 2016

Need for multicriteria evaluation of generic drug policies.

scientific article published on 11 February 2015

OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.

scientific article published on 24 April 2017

Osteoporotic fractures may impair life as much as the complications of diabetes.

scientific article published on 12 September 2017

Overview on Patient Centricity in Cancer Care

scientific article published on 5 October 2017

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

scientific article published on 10 January 2018

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

scientific article

Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016

scientific article published on 08 June 2019

Pitfalls associated with the therapeutic reference pricing practice of asthma medication

scientific article

Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study

scientific article published on 21 February 2019

Policy objective of generic medicines from the investment perspective: The case of clopidogrel.

scientific article published on 7 March 2017

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses

scientific article published on 14 August 2020

Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs

scientific article published on 10 March 2016

Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices.

scientific article published on 26 June 2014

Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development

scientific article

REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE

scientific article published on January 2015

Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt

scientific article published on 13 September 2013

Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications.

scientific article published in May 2004

Response to: Comment on the implications of external price referencing of pharmaceuticals in Middle East countries

scientific article published on 26 December 2015

Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis.

scientific article

Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries

scientific article published on 01 June 2012

Shedding light on the HTA consultancy market: Insights from Poland

scientific article published on 20 August 2019

Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait

article

Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries

scientific article

The European challenges of funding orphan medicinal products

scientific article

The cost effectiveness of Apligraf treatment of diabetic foot ulcers

scientific article published in January 2003

The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids

scientific article published on 31 January 2014

The expanded criteria donor dilemma in cadaveric renal transplantation.

scientific article published on June 2003

The life-years saved by a deceased organ donor

scientific article published in September 2005

The transferability of health technology assessment - the European perspective with focus on central and Eastern European countries

scientific article published on 05 June 2020

The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations

scientific article

Transferability of Economic Evaluations To Central and Eastern Euroepan and Former Soviet Countries

scientific article published on 26 October 2014

Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries.

scientific article published on 18 April 2012

Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.

scientific article published on 8 January 2018

Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study

scientific article published on 14 February 2018

When health technology assessment is confidential and experts have no power: the case of Hungary

scientific article

[Decision analytic modeling and their impact on health care decision making]

scientific article published on 01 January 2009

[Forecasting the number of patients with end-stage renal disease (Model of the system)]

scientific article published on 01 July 2000

[Health prospects in the alternative strategies of renal replacement therapies]

scientific article published on 01 August 2000

[Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis]

scientific article published on 01 August 2002

[Meta-analysis of the side-effect profiles of modern radiation therapies for patients with prostate cancer]

scientific article published on 01 May 2016

[Risk sharing methods in middle income countries]

scientific article published on 01 January 2012

Paulina is supported by:

About Paulina

Help